Skip to main content

Advertisement

ADVERTISEMENT

News

News
01/14/2020
Torrance, CA - January 13, 2020 – Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation and a leader in diagnostic medical imaging systems, along with NZ Technologies of Vancouver Canada and developers of TIPSOTM technology,...
Torrance, CA - January 13, 2020 – Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation and a leader in diagnostic medical imaging systems, along with NZ Technologies of Vancouver Canada and developers of TIPSOTM technology,...
Torrance, CA - January 13, 2020...
01/14/2020
Vascular Disease Management

Advertisement

News
01/09/2020
January 9, 2019 — San Clemente, Calif. – Reflow Medical announces that the Temporary Spur Stent System, a novel retrievable stent technology intended for the treatment of below-the-knee (BTK) peripheral artery disease has been designated for...
January 9, 2019 — San Clemente, Calif. – Reflow Medical announces that the Temporary Spur Stent System, a novel retrievable stent technology intended for the treatment of below-the-knee (BTK) peripheral artery disease has been designated for...
January 9, 2019 — San Clemente,...
01/09/2020
Vascular Disease Management
News
01/08/2020
(January 7, 2020) WAYNE, Pa. — Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces the initiation of the PRELUDE-BTK Study. The purpose of this prospective, single-arm,...
(January 7, 2020) WAYNE, Pa. — Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces the initiation of the PRELUDE-BTK Study. The purpose of this prospective, single-arm,...
(January 7, 2020) WAYNE, Pa. —...
01/08/2020
Vascular Disease Management
News
01/08/2020
Vascular Disease Management

Advertisement

News
12/19/2019
An analysis of data from the ATTRACT trial published in the online version of the January Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVSVL) reveals that quality of life (QOL) measures improve after pharmacomechanical...
An analysis of data from the ATTRACT trial published in the online version of the January Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVSVL) reveals that quality of life (QOL) measures improve after pharmacomechanical...
An analysis of data from the...
12/19/2019
Vascular Disease Management
News
12/11/2019
LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that the first patient has been treated...
LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that the first patient has been treated...
LimFlow SA, a pioneer in the...
12/11/2019
Vascular Disease Management
News
11/22/2019
erit Medical Systems, Inc.,  a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy,...
erit Medical Systems, Inc.,  a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy,...
erit Medical Systems, Inc.,  a...
11/22/2019
Vascular Disease Management

Advertisement

News
11/22/2019
CASTLE PINES, Colo., Nov.
CASTLE PINES, Colo., Nov.
CASTLE PINES, Colo., Nov.
11/22/2019
Vascular Disease Management
News
11/21/2019
Medtronic plc today announced U.S. Food and Drug Administration (FDA) approval of the IN.PACT™ AV drug-coated balloon (DCB), a paclitaxel-coated balloon indicated for the treatment of failing arteriovenous (AV) access in patients with...
Medtronic plc today announced U.S. Food and Drug Administration (FDA) approval of the IN.PACT™ AV drug-coated balloon (DCB), a paclitaxel-coated balloon indicated for the treatment of failing arteriovenous (AV) access in patients with...
Medtronic plc today announced...
11/21/2019
Vascular Disease Management
News
11/20/2019
TOKYO, JAPAN – Nov 20, 2019 – Terumo Corporation (TSE: 4543) today announced that it has decided to acquire Aortica Corporation, a U.S.-based company dedicated to advancing the science of personalised vascular therapy. 
TOKYO, JAPAN – Nov 20, 2019 – Terumo Corporation (TSE: 4543) today announced that it has decided to acquire Aortica Corporation, a U.S.-based company dedicated to advancing the science of personalised vascular therapy. 
TOKYO, JAPAN – Nov 20, 2019 –...
11/20/2019
Vascular Disease Management

Advertisement

Advertisement